AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
about
Sumoylation pathway is required to maintain the basal breast cancer subtypeDual association by TFAP2A during activation of the p21cip/CDKN1A promoterIdentification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cellsGenes regulated by potassium channel tetramerization domain containing 15 (Kctd15) in the developing neural crestInhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinaseAurora-A interacts with AP-2α and down regulates its transcription activityThe direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinomaIdentification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genesInvestigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancerProtein-binding microarray analysis of tumor suppressor AP2α target gene specificity.Activator protein-2α functions as a master regulator of multiple transcription factors in the mouse liverBlood-based biomarkers of aggressive prostate cancer.microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma.Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitroPotential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmaticsRGD Peptides-Conjugated Pluronic Triblock Copolymers Encapsulated with AP-2α Expression Plasmid for Targeting Gastric Cancer Therapy in Vitro and in Vivo.Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiationTumor Suppressor DLEC1 can Stimulate the Proliferation of Cancer Cells When AP-2ɑ2 is Down-Regulated in HCT116.An exact algorithm for finding cancer driver somatic genome alterations: the weighted mutually exclusive maximum set cover problem.Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression.miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions.Epiregulin: roles in normal physiology and cancerThe nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasisTranscription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.Hepatitis B virus regulation of Raf1 promoter activity through activation of transcription factor AP-2α.Molecular predictors of gemcitabine response in pancreatic cancer.Functions of the AP-2α gene in activating apoptosis and inhibiting proliferation of gastric cancer cells both in vitro and in vivo.Longitudinal system-based analysis of transcriptional responses to type I interferons.Current Challenges and Opportunities in Treating Glioblastoma.MDM2 Overexpression Modulates the Angiogenesis-Related Gene Expression Profile of Prostate Cancer Cells.
P2860
Q24297866-EA10DBA3-822A-421C-AACB-F170472F866DQ24307618-FAFD1056-CABB-49D3-B1AD-93998DC04E11Q24626014-7D81E2B4-2506-46D6-9E8D-84B8B19109CCQ28312135-05CD04DD-9BBD-450D-A285-E8959FC347B4Q28312142-0CA21892-3549-47E4-8004-5018E9194A06Q28507077-A539B75D-9B1F-46AC-B19B-4675CB29E33CQ28741932-C0823DC8-BF48-4614-A908-0317C7BBB5A8Q33492610-0EB9E05A-72E3-4DED-BCCA-BDAE1FA89905Q33501737-C7AC5266-370C-4936-BB3A-37AE863A97E8Q33595109-2FF8DC10-2B8D-41A4-95EA-C7355388B3C1Q33627215-582F8432-9020-49AC-9A4F-0F1EB11FAEC7Q33871764-E086E951-8019-4013-92C0-AB2F6D6DBA76Q34005395-760147C3-C7B4-47BC-88C1-CC3F3C02D17EQ34193484-FCF44E31-E034-4CF4-B4CB-D2AA5DC6B73FQ34448347-5F31770F-651F-4602-872C-6738D69237F0Q34993968-5AFDC96C-BFA7-4941-A5C7-3CC9F8F7424AQ35065342-3FB076FA-0BC9-4CE6-9305-9A3C127DA5A4Q35268434-005611B6-F4D1-40EF-8DF4-A066274686AFQ35857559-88D01E12-F058-4CF1-A881-1B311AEC3D34Q35859198-6CC63A7E-0BCD-4DC4-8895-183C7EC915A9Q35902627-7403CA17-EEFC-485B-82BF-8E0CAC8956BCQ36180219-07579706-8BF5-4359-9E46-9065C0A630D9Q36492551-8990DC0A-B7B2-4C1B-9A61-454C75B71B9CQ36865843-31097F1B-0960-4DAA-9908-5B2824680D47Q37330687-89C0548B-19F9-4177-87E5-161A10C83EC0Q37439422-8333F279-B059-4D61-901D-1ED9BE5745E7Q38196137-5CFF2400-8A0F-4775-AEB3-C926E2B7A6B4Q38720370-8B84CEF7-FF99-4540-AEAB-640C46B75AFDQ38894951-7946BCF9-2114-498A-88B8-F29C71B3EEC0Q39081952-C7909994-A2A0-4A28-AEC7-B2FC1A6D692BQ39229719-9FF408B5-217D-4470-A206-1A0D9EE6AD96Q39250668-F60A73FF-AB64-452D-8BA8-B62FA11F46CBQ45875109-181847FA-A474-4B5C-A1D4-CB504A593B01Q46262683-BAABD2CC-0DC7-451F-ADC9-EC037F3BECDEQ52579808-F43215C3-2C01-40AB-906A-BFC622BC5D15Q55096107-8139EE30-F603-4C9F-9989-13A328CDD232
P2860
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@ast
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@en
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@nl
type
label
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@ast
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@en
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@nl
prefLabel
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@ast
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@en
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
@nl
P2093
P50
P356
P1433
P1476
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs
@en
P2093
Daniela Cimino
Elena Astanina
Elisa Penna
Francesca Orso
Michele De Bortoli
P304
P356
10.1096/FJ.08-106492
P407
P577
2008-04-28T00:00:00Z